Back
Lumos Pharma 10K Form
Sell
38
LUMO
Lumos Pharma
Last Price:
3.95
Seasonality Move:
-11.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LUMO News And Ratings
See the #1 stock for the next 7 days that we like better than LUMO
LUMO Financial Statistics
Sales & Book Value
| Annual Sales: | $2.05M |
|---|---|
| Cash Flow: | $-6.38M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.26 |
| Price / Book: | 3.02 |
Profitability
| EPS (TTM): | -4.43000 |
|---|---|
| Net Income (TTM): | $-35.75M |
| Gross Margin: | $934K |
| Return on Equity: | -133.22% |
| Return on Assets: | -92.04% |
Lumos Pharma Earnings Forecast
Key Lumos Pharma Financial Ratios
- The Gross Profit Margin over the past 2 years for LUMO is 100.00%.
- The Selling, General & Administrative Expenses for LUMO have been equal to 807.85% of Gross Profit Margin.
- The Research & Development expenses have been 1,077.33% of Revenue.
- The Interest Expense is -0.52% of Operating Income.
- Per Share Earnings over the last 16 years have been positive in 6 years.
Lumos Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LUMO |
| CUSIP: | 55028X |
| Website: | lumos-pharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.23 |
| Quick Ratio: | 3.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LUMO Technical Analysis vs Fundamental Analysis
Sell
38
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy or a Sell?
-
Lumos Pharma stock is rated a Sell
The current Lumos Pharma [LUMO] share price is $3.82. The Score for LUMO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.